# Post-cesarean Analgesia With Epidural Morphine Following Epidural 2-chloroprocaine

> **NCT04369950** · PHASE4 · COMPLETED · sponsor: **The University of Texas Health Science Center, Houston** · enrollment: 44 (actual)

## Conditions studied

- Physiological Effect of Drugs
- Morphine
- Analgesics
- Analgesics, Opioid
- Central Nervous System Depressants
- Narcotics

## Interventions

- **DRUG:** 2% lidocaine with 1:200,000 epinephrine and epidural morphine
- **DRUG:** 3% 2-chloroprocaine and epidural morphine

## Key facts

- **NCT ID:** NCT04369950
- **Lead sponsor:** The University of Texas Health Science Center, Houston
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-05-11
- **Primary completion:** 2021-05-11
- **Final completion:** 2021-07-11
- **Target enrollment:** 44 (ACTUAL)
- **Last updated:** 2022-05-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04369950

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04369950, "Post-cesarean Analgesia With Epidural Morphine Following Epidural 2-chloroprocaine". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04369950. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
